Timothy P. Walbert - 01 Feb 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Chairman, President and CEO, Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Feb 2022
Net transactions value
-$355,341
Form type
4
Filing time
02 Feb 2022, 15:25:05 UTC
Previous filing
31 Jan 2022
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $0 +9,087 +26% $0.000000 44,690 01 Feb 2022 By spouse
transaction HZNP Ordinary Shares Tax liability $355,341 -3,767 -8.4% $94.33 40,923 01 Feb 2022 By spouse
holding HZNP Ordinary Shares 585,549 01 Feb 2022 Direct
holding HZNP Ordinary Shares 107,739 01 Feb 2022 See footnote F1
holding HZNP Ordinary Shares 100,300 01 Feb 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units (RSUs) Options Exercise $0 -9,087 -100% $0.000000* 0 01 Feb 2022 Ordinary Shares 9,087 By spouse F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F2 The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F3 Each RSU represents a contingent right to receive one ordinary share of the Issuer.
F4 The RSU's vest 1/3 annually on each anniversary of February 1, 2019 (the grant date).